Ken Griffin’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-186,711
| Closed | -$180K | – | 15084 |
|
|
2024
Q4 | $177K | Buy |
186,711
+99,510
| +114% | +$93.9K | ﹤0.01% | 10631 |
|
|
2024
Q3 | $87.2K | Sell |
87,201
-140,660
| -62% | -$156K | ﹤0.01% | 11302 |
|
|
2024
Q2 | $283K | Buy |
227,861
+38,452
| +20% | +$39.2K | ﹤0.01% | 9259 |
|
|
2024
Q1 | $246K | Sell |
189,409
-8,551
| -4% | -$9.75K | ﹤0.01% | 9896 |
|
|
2023
Q4 | $247K | Buy |
197,960
+44,614
| +29% | +$49.4K | ﹤0.01% | 9543 |
|
|
2023
Q3 | $199K | Sell |
153,346
-61,150
| -29% | -$98.8K | ﹤0.01% | 9915 |
|
|
2023
Q2 | $369K | Buy |
214,496
+128,508
| +149% | +$204K | ﹤0.01% | 8584 |
|
|
2023
Q1 | $126K | Sell |
85,988
-125,619
| -59% | -$241K | ﹤0.01% | 10928 |
|
|
2022
Q4 | $343K | Sell |
211,607
-235,676
| -53% | -$542K | ﹤0.01% | 9020 |
|
|
2022
Q3 | $1.5M | Sell |
447,283
-436,073
| -49% | -$1.97M | ﹤0.01% | 6159 |
|
|
2022
Q2 | $3.21M | Buy |
883,356
+211,751
| +32% | +$960K | ﹤0.01% | 4632 |
|
|
2022
Q1 | $4.86M | Sell |
671,605
-18,207
| -3% | -$155K | ﹤0.01% | 4228 |
|
|
2021
Q4 | $9.38M | Sell |
689,812
-12,057
| -2% | -$189K | ﹤0.01% | 3192 |
|
|
2021
Q3 | $14.7M | Sell |
701,869
-65,739
| -9% | -$1.41M | ﹤0.01% | 2449 |
|
|
2021
Q2 | $18.4M | Sell |
767,608
-81,440
| -10% | -$2.06M | ﹤0.01% | 2186 |
|
|
2021
Q1 | $24.9M | Sell |
849,048
-83,837
| -9% | -$2.46M | 0.01% | 1721 |
|
|
2020
Q4 | $27.9M | Buy |
+932,885
| New | +$29.3M | 0.01% | 1461 |
|
Ken Griffin's KRON Position: Q1 2025 in Review
Ken Griffin sold out of Kronos Bio (KRON) in Q1 2025, closing a stake of 186,711 shares — an estimated $180K sold.
Ken Griffin first reported a position in KRON in Q4 2020 and held it in 17 quarters. The position peaked at $27.9M in Q4 2020. 47 funds tracked by Wall St. Rank hold KRON as of Q1 2025.
- Ken Griffin reported no remaining Kronos Bio position as of Q1 2025 after selling out during the quarter.
- Ken Griffin sold 186,711 Kronos Bio shares in Q1 2025, an estimated $180K.
- Ken Griffin first reported a position in Kronos Bio in Q4 2020 and held it in 17 quarters.
- Ken Griffin's Kronos Bio position peaked at $27.9M in Q4 2020.
- 47 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2025.
Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.